Cisplatin Overdose Roger Y. TsangTurki Al-FayeaHeather-Jane Au Practical Drug Safety 03 January 2013 Pages: 1109 - 1122
Benefit-Risk Assessment of Leflunomide Nicola AlcornSarah SaundersRajan Madhok Review Article 03 January 2013 Pages: 1123 - 1134
Improving Follow-Up Rates in Spontaneous Adverse Drug Reaction Reporting Christopher AntonAnthony R. CoxRobin E. Ferner Short Communication 03 January 2013 Pages: 1135 - 1140
Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in Singapore Min-Yong LowYun ZengHwee-Ling Koh Short Communication 03 January 2013 Pages: 1141 - 1146
Messages about Black-Box Warnings Pierre L. YongCabral BigmanJudith A. Long Original Research Article 03 January 2013 Pages: 1147 - 1157
The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder Gerald GartlehnerKylie ThalerBradley N. Gaynes Original Research Article 03 January 2013 Pages: 1159 - 1173
Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval Thijs J. GiezenAukje K. Mantel-TeeuwisseHubert G. M. Leufkens Original Research Article 03 January 2013 Pages: 1175 - 1187
Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions Arjen F. J. GeertsFred H. P. De KoningToine C. G. Egberts Original Research Article 03 January 2013 Pages: 1189 - 1197